A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles
Open accessThe DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Abstract
Our aim was to determine the quantitative effects of a single-dose of Nattokinase (NK) administration on coagulation/fibrinolysis parameters comprehensively in healthy male subjects. A double-blind, placebo-controlled cross-over NK intervention study was carried out in 12 healthy young males. Following the baseline blood draw, each subject was randomized to receive either a single-dose of 2,000 FU NK (NSK-SD, Japan Bio Science Laboratory Co., Ltd) or placebo with subsequent cross-over of the groups. Subjects donated blood samples at 2, 4, 6 and 8 hours following administration for analysis of coagulation/fibrinolysis parameters. As a result, D-dimer concentrations at 6 and 8 hours and blood fibrin/fibrinogen degradation products at 4 hours after NK administration elevated significantly (p < 0.05, respectively). Factor VIII activity declined at 4 and 6 hours (p < 0.05, respectively), blood antithrombin concentration was higher at 2 and 4 hours (p < 0.05, respectively) and the activated partial thromboplastin time prolonged significantly at 2 and 4 hours following NK administration (p < 0.05 and p < 0.01, respectively). All the changes, however, were within the normal range. In conclusion, thus, a single-dose of NK administration appears enhancing fibrinolysis and anti-coagulation via several different pathways simultaneously.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Anti-thrombotic and anti-hypertensive activities of nattokinase have been demonstrated in small RCTs in humans [127,128].”
From Fermented foods: definitions and characteristics, impact on the gut microbiota and effects on gastrointestinal health and disease (2019) · cites this paper as [128]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sumi, H., Hamada, H., Tsushima, H., Mihara, H., & Muraki, H. (1987) · Experientia · doi:10.1007/bf01956052 · Cited by 570
Diabetes mellitus as a prothrombotic condition
Grant, P. J. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01824.x · Cited by 443
Stahl, M. L., & Ferrari, E. (1984) · Journal of Bacteriology · doi:10.1128/jb.158.2.411-418.1984 · Cited by 309
Fujita, M., Nomura, K., Hong, K., Ito, Y., Asada, A., & Nishimuro, S. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2624 · Cited by 306
Enhancement of the Fibrinolytic Activity in Plasma by Oral Administration of Nattokinases
Sumi, H., Hamada, H., Nakanishi, K., & Hiratani, H. (1990) · Acta Haematologica · doi:10.1159/000205051 · Cited by 304
Inflammation, sepsis, and coagulation.
Esmon, C. T., Fukudome, K., Mather, T., Bode, W., Regan, L. M., Stearns-Kurosawa, D. J., & Kurosawa, S. (1999) · PubMed · Cited by 252
Butenas, S., Mann, K. G., & Butenas (2002) · Biochemistry (Moscow) · doi:10.1023/a:1013985911759 · Cited by 203
Urano, T., Ihara, H., Umemura, K., Suzuki, Y., Oike, M., Akita, S., Tsukamoto, Y., Suzuki, I., & Takada, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101751200 · Cited by 167
Thrombolytic Effect of Nattokinase on a Chemically Induced Thrombosis Model in Rat.
FUJITA, M., HONG, K., ITO, Y., FUJII, R., KARIYA, K., & NISHIMURO, S. (1995) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.18.1387 · Cited by 147
Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons.
Taylor, F. B., Emerson, T. E., Jordan, R. E., Ak, C., & Blick, K. E. (1988) · PubMed · Cited by 144
Research works printed but not linked: 1
- Fukuda, S., Matsui, T., Tachibana, H., Tomoda, T. & Ohsugi, M. Development of functional soybean foods produced by fermentation with mushroom mycelia. Bull Mukogawa Women’s Univ Nat Sci. 55, 53–59 (2007).
Cited by
Dimidi, E., Cox, S., Rossi, M., & Whelan, K. (2019) · Nutrients · doi:10.3390/nu11081806 · Cited by 801
“Anti-thrombotic and anti-hypertensive activities of nattokinase have been demonstrated in small RCTs in humans [127,128].”
BackgroundHealth benefits of fermented foods
Şanlier, N., Gökcen, B. B., & Sezgin, A. C. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1383355 · Cited by 789
“Nattokinase, a serine fibrinolytic enzyme, has anti-coagulant, anti-thrombotic and fibrinolytic properties and may play a role in the prevention of cardiovascular disease and hypertension (Dabbagh et al. 2014; Kurosawa et al. 2015; Lee, Lai, and Wu 2015; Shirole, Sharma, and Jagtap 2013).”
BackgroundMechanisms of long COVID and the path toward therapeutics
Peluso, M. J., & Deeks, S. G. (2024) · Cell · doi:10.1016/j.cell.2024.07.054 · Cited by 341
Recent progress in multienzymes co-immobilization and multienzyme system applications
Ren, S., Li, C., Jiao, X., Jia, S., Jiang, Y., Bilal, M., & Cui, J. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.05.141 · Cited by 342
Fermented foods and gastrointestinal health: underlying mechanisms
Mukherjee, A., Breselge, S., Dimidi, E., Marco, M. L., & Cotter, P. D. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00869-x · Cited by 245
“The potential clinical impact of nattokinase on hypertension and as a fibrinolytic agent has been demonstrated through several animal and human studies 44,48–50 .”
Bioactivity of soy-based fermented foods: A review
Cao, Z.-H., Green-Johnson, J. M., Buckley, N. D., & Lin, Q.-Y. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.12.001 · Cited by 231
Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease
Weng, Y., Yao, J., Sparks, S., & Wang, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030523 · Cited by 192
Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases
Chen, H., McGowan, E. M., Ren, N., Lal, S., Nassif, N., Shad-Kaneez, F., Qu, X., & Lin, Y. (2018) · Biomarker Insights · doi:10.1177/1177271918785130 · Cited by 168
Fermented foods: An update on evidence-based health benefits and future perspectives
Diez-Ozaeta, I., & Astiazaran, O. J. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111133 · Cited by 162
Fermented Soy Products and Their Potential Health Benefits: A Review
do Prado, F. G., Pagnoncelli, M. G. B., Pereira, G. V. D. M., Karp, S. G., & Soccol, C. R. (2022) · Microorganisms · doi:10.3390/microorganisms10081606 · Cited by 187
Nagata, C., Wada, K., Tamura, T., Konishi, K., Goto, Y., Koda, S., Kawachi, T., Tsuji, M., & Nakamura, K. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.137281 · Cited by 162
Qiao, Y., Zhang, K., Zhang, Z., Zhang, C., Sun, Y., & Feng, Z. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111575 · Cited by 133
Hu, Y., Yu, D., Wang, Z., Hou, J., Tyagi, R., Liang, Y., & Hu, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-45686-y · Cited by 93
Biotechnology, Bioengineering and Applications of Bacillus Nattokinase
Li, Y., Chen, L., Tang, X., & Li, J. (2022) · Biomolecules · doi:10.3390/biom12070980 · Cited by 78
Jensen, G., Lenninger, M., Ero, M. P., & Benson, K. (2016) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s99553 · Cited by 71
Kell, D. B., & Pretorius, E. (2022) · Biochemical Journal · doi:10.1042/bcj20220154 · Cited by 81
Ali, A. M. M., & Bavisetty, S. C. B. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.303 · Cited by 65
Recent Advances in Nattokinase-Enriched Fermented Soybean Foods: A Review
Li, D., Hou, L., Hu, M., Gao, Y., Tian, Z., Fan, B., Li, S., & Wang, F. (2022) · Foods · doi:10.3390/foods11131867 · Cited by 56
Fibrinolytic Enzymes for Thrombolytic Therapy
Kumar, S. S., & Abdulhameed, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7709-9_15 · Cited by 60
Insulin Delivery Using Dynamic Covalent Boronic Acid/Ester‐Controlled Release
Banach, Ł., Williams, G. T., & Fossey, J. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100118 · Cited by 43
Takabayashi, T., Imoto, Y., Sakashita, M., Kato, Y., Tokunaga, T., Yoshida, K., Narita, N., Ishizuka, T., & Fujieda, S. (2017) · Allergology International · doi:10.1016/j.alit.2017.03.007 · Cited by 43
Thrombolytic Enzymes of Microbial Origin: A Review
Diwan, D., Usmani, Z., Sharma, M., Nelson, J. W., Thakur, V. K., Christie, G., Molina, G., & Gupta, V. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910468 · Cited by 45
Fibrin and Fibrinolytic Enzyme Cascade in Thrombosis: Unravelling the Role
Singh, R., Gautam, P., Sharma, C., & Osmolovskiy, A. A. (2023) · Life · doi:10.3390/life13112196 · Cited by 40
Development of fermented chestnut with Bacillus natto: Functional and sensory properties
Dong, M., An, J.-Y., Wang, L., Fan, X.-H., Lv, M., Zhu, Y., Chang, Y., Meng, D., Yang, Q., & Fu, Y. (2019) · Food Research International · doi:10.1016/j.foodres.2019.108941 · Cited by 35
Bioactive compounds in fermented foods: a systematic narrative review
Künili, İ. E., Akdeniz, V., Akpınar, A., Ozturkoglu‐Budak, S., Curiel, J. A., Güzel, M., Karagözlü, C., Kaşıkçı, M. B., Caruana, M., Starowicz, M., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1625816 · Cited by 43
“It also reduces thrombin and Factor Xa activity, increases antithrombin levels, and lowers Factor VIII, offering both anticoagulant and fibrinolytic effects with prolonged activity (35, 52).”
InfluentialZhang, X., Tong, Y., Wang, J., Lyu, X., & Yang, R. (2021) · Journal of Dairy Science · doi:10.3168/jds.2020-19756 · Cited by 33
Diverse origins of fibrinolytic enzymes: A comprehensive review
Hazare, C., Bhagwat, P. K., Singh, S., & Pillai, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26668 · Cited by 43
“This effect is associated with increased concentrations of D-dimer, FDP, and antithrombin in the blood, while a significant decrease in factor VIII was observed [164].”
BackgroundUse of Exogenous Enzymes in Human Therapy: Approved Drugs and Potential Applications
Cioni, P., Gabellieri, E., Campanini, B., Bettati, S., & Raboni, S. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210713094722 · Cited by 35
Zhang, S., Gao, C., Lü, S., He, J., Liu, M., Wu, C., Liu, Y., Zhang, X., & Liu, Z. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.08.009 · Cited by 31
Natto and miso: an overview on their preparation, bioactive components and health-promoting effects
Chan, E. W. C., Wong, S. K., Kezuka, M., Oshiro, N., & Chan, H. T. (2021) · Food Research · doi:10.26656/fr.2017.5(3).587 · Cited by 35
“Among the bioactive components of natto, NK possesses anti-thrombotic and anti-coagulant activities as shown by animal studies (Fujita et al., 1995) and human trials (Kurosawa et al., 2015).”
BackgroundImproved blood compatibility of polysulfone membrane by anticoagulant protein immobilization
Ji, M., Chen, X., Luo, J., & Wan, Y. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.12.026 · Cited by 28
Data Recorded in Real Life Support the Safety of Nattokinase in Patients with Vascular Diseases
Gallelli, G., Mizio, G. D., Palleria, C., Siniscalchi, A., Rubino, P., Muraca, L., Cione, E., Salerno, M., Sarro, G. D., & Gallelli, L. (2021) · Nutrients · doi:10.3390/nu13062031 · Cited by 31
“[26] reported an increase in D-dimer blood antithrombin concentrations and a decrease in Factor VIII activity with a single nattokinase dose (2000 FU).”
BackgroundChen, H., Chen, J., Zhang, F., Li, Y., Wang, R., Zheng, Q., Zhang, X., Zeng, J., Xu, F., & Lin, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.964977 · Cited by 38
Nattokinase atherothrombotic prevention study: A randomized controlled trial
Hodis, H. N., Mack, W. J., Meiselman, H. J., Kalra, V. K., Liebman, H. A., Hwang-Levine, J., Dustin, L., Kono, N., Mert, M., Wenby, R. B., et al. (2021) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-211147 · Cited by 27
Nattokinase: Structure, applications and sources
Jamali, N., Vahedi, F., Fard, E. S., Taheri‐Anganeh, M., Taghvimi, S., Khatami, S. H., Ghasemi, H., & Movahedpour, A. (2022) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2022.102564 · Cited by 26
Zhou, X., Liu, L., & Zeng, X. (2021) · Food Structure · doi:10.1016/j.foostr.2021.100219 · Cited by 27
Fibrinolytic characteristics of Bacillus subtilis G8 isolated from natto
Pinontoan, R., Elvina, E., Sanjaya, A., & Jo, J. (2021) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2020-071 · Cited by 23
“It has also been reported that those subjects who ingested capsules of nattokinase experienced certain nattokinase-associated health benefits, including control of blood pressure [10] and activation of fibrinolysis [11].”
BackgroundNattokinase attenuates endothelial inflammation through the activation of SRF and THBS1
Chiu, H., Chou, C., Lee, K.-T., Shih, C.-C., Huang, T.-H., & Sung, L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131779 · Cited by 24
Optimizing near-infrared-activated gold nanostructures for targeted combination cancer therapy
Shukla, N., Das, R., Rodriguez, C. Y. C., Mukhanova, E., Soldatov, A. V., Bathla, A., kumari, I., Hauserao, N., & Belbekhouche, S. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114687 · Cited by 24
Strategies for the Management of Spike Protein-Related Pathology
Halma, M. T. J., Plothe, C., Marik, P. E., & Lawrie, T. A. (2023) · Microorganisms · doi:10.3390/microorganisms11051308 · Cited by 23
“Experiments have demonstrated that it potently degrades spike protein [202,203], which is an added benefit in addition to its fibrinolytic and anti-coagulant properties [204].”
BackgroundGranito, M., Alvarenga, L., Ribeiro, M. M., Carvalhosa, P., Andrade, T., Mesquita, C. T., Stockler‐Pinto, M. B., Mafra, D., & Cardozo, L. (2024) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2024.2416663 · Cited by 24
Bioengineered heparin: Advances in production technology
Sultana, R., & Kamihira, M. (2024) · Biotechnology Advances · doi:10.1016/j.biotechadv.2024.108456 · Cited by 20
Nattokinase: An Updated Critical Review on Challenges and Perspectives
Selvarajan, E., & Bhatnagar, N. (2017) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/1871525716666171207153332 · Cited by 22
Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination
Hulscher, N., Procter, B. C., Wynn, C., & McCullough, P. A. (2023) · Cureus · doi:10.7759/cureus.49204 · Cited by 28
“Nattokinase has been shown to be largely safe other than possible excessive bleeding especially when combined with other medications [48].”
BackgroundInfluentialUemura, H., Katsuura‐Kamano, S., Nakamoto, M., Yamaguchi, M., Fujioka, M., Iwasaki, Y., & Arisawa, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-28038-0 · Cited by 18
Syahbanu, F., Giriwono, P. E., Tjandrawinata, R. R., & Suhartono, M. T. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05898-2 · Cited by 16
Kumar, S. S., & Abdulhameed, S. (2017) · Springer eBooks · doi:10.1007/978-981-10-4284-3_2 · Cited by 16
Exploring autophagy in treating SARS-CoV-2 spike protein-related pathology
Halma, M. T. J., Marik, P. E., & Saleeby, Y. M. (2024) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2024.100163 · Cited by 14
Grixti, J. M., Theron, C. W., Salcedo-Sora, J. E., Pretorius, E., & Kell, D. B. (2024) · Journal of Experimental and Clinical Application of Chinese Medicine · doi:10.62767/jecacm504.6557 · Cited by 17
Yoo, H. J., Kim, M., Kim, M., Lee, A., Jin, C., Lee, S. P., Kim, T. S., Lee, S., & Lee, J. H. (2019) · Food & Function · doi:10.1039/c8fo02324g · Cited by 17
Unsaturated fatty acids enhance the fibrinolytic activity of subtilisin NAT (nattokinase)
Takagaki, S., Suzuki, M., Suzuki, E., & Hasumi, K. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13326 · Cited by 15
Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications
Derosa, G., Maffioli, P., D’Angelo, A., & Pierro, F. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.582556 · Cited by 16
Wu, H., Zhang, Q., Suo, H., Xu, F., Huang, W., & Wang, D. O. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250198 · Cited by 15
Liu, M., Xu, Z., Wang, Z., Wang, D., Yang, M., Li, H., Zhang, W., He, R., Cheng, H., Guo, P., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1380727 · Cited by 14
Ghahfarrokhi, S. S. M., Mahdigholi, F. S., & Amin, M. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03713-7 · Cited by 14
“It is important to note that no adverse effects were observed in either the Nattokinase or placebo groups during the supplementation period The article (Kurosawa et al. 2015) investigated how giving a single dose of Nattokinase (NK) affects coagulation and fibrinolysis in healthy male participants.”
BackgroundCo‐production of nattokinase and α ‐amylase from Bacillus natto fermentation using okara
Li, P., Hu, Y., Li, Y., Bao, Y., Wang, X., & Piao, C. (2022) · Journal of Food Processing and Preservation · doi:10.1111/jfpp.17130 · Cited by 11
Li, G., Li, T., He, F., Chen, C., Xu, X., Tian, W., Yang, Y., He, X., Li, H., Chen, K., et al. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2378 · Cited by 11
Advancements in Targeted Quantum Dots Structures for Enhanced Cancer Treatment
Shukla, N., Cárdenas, C. Y., Chanderiya, A., Polozhentsev, O. E., Das, R., Vyas, S., Mukhanova, E., Soldatov, A. V., & Belbekhouche, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17111396 · Cited by 9
“In one study, quantum dots and melphalan were linked to a hyaluronic acid framework to form a polymer-drug conjugate [112].”
du Preez, H. N., Lin, J., Maguire, G. E. M., Aldous, C. M., & Kruger, H. G. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14296 · Cited by 13
Research progress on the fibrinolytic enzymes produced from traditional fermented foods
Wang, P., Peng, C., Xie, X., Deng, X., & Weng, M. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3601 · Cited by 11
“(thrombolysis and anti-coagulation) 4 h after NK administration in 12 subjects who received a single dose of NK 2000 FU or placebo, followed by a group crossover (Kurosawa et al., 2015).”
Li, X., Long, J., Gao, Q., Pan, M., Wang, J., Yang, F., & Zhang, Y. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2408234 · Cited by 14
“Even a single dose of oral nattokinasewas shown to enhance fibrinolysis and anticoagulation in humans [22,39].”
BackgroundWu, H., Wang, H., Li, W., Zhang, C., Liu, Y., Xu, F., Chen, J., Duan, L., & Zhang, F. (2019) · Glycoconjugate Journal · doi:10.1007/s10719-019-09860-8 · Cited by 10
Mahakalakar, N., Mohariya, G., Taksande, B. G., Kotagale, N. R., Umekar, M. J., & Vinchurney, M. D. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149352 · Cited by 11
Bhatt, T. C., Mandaliya, V. B., Ibrahim, M., Bhimani, A., Detroja, A., Koradiya, J., Sanghvi, G. V., & Bishoyi, A. K. (2025) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2025.100316 · Cited by 9
Huang, X., Gao, X., Huang, J., Luo, Y., Wei, T., Guo, M., Liu, Y., Wu, J., Chen, Y., & Liu, Y. (2024) · Process Biochemistry · doi:10.1016/j.procbio.2024.05.017 · Cited by 7
Vianney, Y. M., Tjoa, S. E. E., Aditama, R., & Putra, S. E. D. (2019) · Journal of Molecular Modeling · doi:10.1007/s00894-019-4225-y · Cited by 7
Muric, M. D., Nikolic, M. R., Todorović, A., Jakovljevic, V. L., & Vučićević, K. (2024) · Biomolecules · doi:10.3390/biom14080956 · Cited by 7
“Various experimental and clinical studies reported the positive effects of NK on the circulatory system regarding its thrombolytic and anticoagulant actions [10,11].”
BackgroundJain, A., Anand, P. K., & Kaur, J. (2024) · Biochimie · doi:10.1016/j.biochi.2024.09.014 · Cited by 6
Safety assessment of subtilisin QK in rats
Xiao, S., Hu, D., Gao, Y., Ai, Y., Luo, S., Chen, S., Wang, B., Zhou, L., Dong, Y., & Wang, Y. (2021) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-021-00506-w · Cited by 6
“Volunteer experiments showed that a single oral dose of 2000 FU nattokinase had excellent thrombolysis and anticoagulation effects and no adverse effects [10, 11].”
BackgroundSafety of fermented soybean extract NSK‐SD® as a novel food pursuant to Regulation (EC) No 258/97
EFSA Panel on Dietetic Products, N. A. A. (. (2016) · EFSA Journal · doi:10.2903/j.efsa.2016.4541 · Cited by 10
Ashokan, A. K., & Mohanasrinivasan, V. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-07102-1 · Cited by 5
“…u l fi b r i n o l y t i c / a n t i c o a g u l a n t a g e n t t o r e d u c e t h e r i s k o f t h r o m b o s i s a n d C V D i n h u m a n s [ 142 ] 2013 U S A P h a r m a c o k i n e t i c s N K c a n b e m e a s u r e d d i r e c t l y i n t h e h u m a n b l oo d a f t e r s i n g l e d o…”
Zhang, Z., Gao, F., Mao, J., Liu, J., Zeng, Z., Zhou, Y., Tao, W., Wang, W., Lyu, G., Xu, L., et al. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114509 · Cited by 5
Preparation of a novel mixed milk with nattokinase produced byBacillus subtilis(natto)
Nie, G., Liu, N., Zhang, E., Zhao, R., Zhang, X., Zhu, X., Li, H., Nie, Z., & Yue, W. (2017) · Journal of Food Processing and Preservation · doi:10.1111/jfpp.13284 · Cited by 5
Itaya, M., Nagasaku, M., Shimada, T., Ohtani, N., Shiwa, Y., Yoshikawa, H., Kaneko, S., Tomita, M., & Sato, M. (2019) · FEMS Microbiology Letters · doi:10.1093/femsle/fnz032 · Cited by 8
LRRFIP1 expression triggers platelet agglutination by enhancing αIIbβ3 expression
Yin, X., Liu, P., Liu, Y., Liu, M., Fan, W., Liu, B., & Zhao, J. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7571 · Cited by 5
Biopharmaceuticals: A review of their development and contribution to healthcare
Liew, K. B., Lee, S.-K., Ming, L. C., Uddin, A. B. M. H., Sarker, M. Z. I., Chew, Y.-L., & Kee, P. E. (2023) · Biomedical and Biopharmaceutical Research · doi:10.19277/bbr.20.2.321 · Cited by 10
Wang, P., Peng, C., Li, M., Cheng, M., Fang, X., Deng, Z., Weng, M., Deng, X., & Xie, X. (2024) · Journal of Food Science and Technology · doi:10.1007/s13197-024-06051-8 · Cited by 4
“Kurosawa et al. carried out 12 healthy young males to determine the quantitative effects of a single-dose of Nattokinase (NK) administration on coagulation/fibrinolysis parameters comprehensively (Kurosawa et al. 2015).”
Production of fibrinolytic enzymes during food production
Ali, A. M. M., Bavisetty, S. C. B., Gullo, M., Lertsiri, S., Morris, J. M., & MASSA, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823506-5.00018-7 · Cited by 7
Kapoor, R., Khowal, S., Panda, B. P., & Wajid, S. (2022) · Biotechnology Letters · doi:10.1007/s10529-022-03226-1 · Cited by 5
Understanding the concept of Nattokinase use: a few years after beginning
Maslarov, D. B., Drenska, D., Maslarova-Gelov, J., & Gelov, I. (2023) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2023.2249552 · Cited by 4
Nattokinase-Associated Hemoperitoneum in an Elderly Woman
Ramachandran, L., Aqeel, A., Jafri, A., Sidhu, Y., & Djirdeh, T. M. (2021) · Cureus · doi:10.7759/cureus.20074 · Cited by 3
“Studies have also demonstrated an increase in activity of fibrinolysis and anticoagulant parameters between 2 and 8 hours after nattokinase intake [7].”
BackgroundZhou, Y., Yu, B., Xie, C., Liu, M., Long, T., & Liang, Z. (2025) · Biomedicines · doi:10.3390/biomedicines13061277 · Cited by 3
Facile synthesis of magnetic iron oxide nanoparticles for nattokinase isolation
Liu, C., Lai, H.-Y., & Wu, W. (2017) · Food and Bioproducts Processing · doi:10.1016/j.fbp.2017.01.006 · Cited by 3
X-Ray Crystallography in Structure-Function Characterization of Therapeutic Enzymes
Papageorgiou, A. C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7709-9_4 · Cited by 3
Wang, D., Kou, Y., Guo, T., Duan, L., Chen, J., Duzhou, C., Huang, T., Liu, X., Deng, Y., & Song, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122935 · Cited by 3
Wang, J., Xu, S., Chen, L., Zheng, P., Song, R., Song, Y., Sun, J., & Zhang, B. (2025) · Foods · doi:10.3390/foods14203482 · Cited by 3
“NK decreases plasminogen activator inhibitor-1 (PAI-1) and increases tissue plasminogen activator (tPA), enhancing endogenous fibrinolysis [13]; it also elevates antithrombin levels and inhibits collagen-or thrombin-induced platelet aggregation, thereby preventing thrombosis [14].”
Ha, N. T. T., Vuong, N. L., Lụa, T. T., Nguyen, T., Nghia, D. T., Nga, H. T. V., Anh, P. T. V., Thai, T. T., & Dung, D. V. (2020) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2020.101060 · Cited by 2
Choi, J. H., Kim, J., Shin, T., Ryu, M. S., Yang, H.-J., Jeong, D., Son, H.-S., & Unno, T. (2022) · Microbiology and Biotechnology Letters · doi:10.48022/mbl.2208.08003 · Cited by 3
Kim, Y.-C., Won, S., & Jeong, B. (2025) · Transboundary and Emerging Diseases · doi:10.1155/tbed/9527934 · Cited by 2
Nattokinase: A hope in cardiovascular therapy and more
EFESC, F., & IONESCU, D.-D. (2020) · Romanian Journal of Medical Practice · doi:10.37897/rjmp.2020.3.2 · Cited by 2
“273 de urokinază din prourokinază, stimularea t-PA (tissue plasminogen activator) ce generează plasmină din plasminogen și inhibiția PAI-1 (plasminogen activation inhibitor 1) prin proteoliză; există și dovezi experimentale că nattokinaza este capabilă să degradeze direct fibrina din trombi [3-7].”
BackgroundYoo, J. Y., Yao, Z., Lee, S. J., Jeon, H. S., & Kim, J. (2021) · Microbiology and Biotechnology Letters · doi:10.48022/mbl.2104.04012 · Cited by 2
Dalal, D., & Gawali, V. P. (2023) · Indian Journal of Pharmacy and Pharmacology · doi:10.18231/j.ijpp.2023.011 · Cited by 2
Nattokinase historical sketch on experimental and clinical evidence
Micco, P. D., Bernardi, F. F., Camporese, G., Biglietto, M., Perrella, A., Ciarambino, T., Russo, V., & Imbalzano, E. (2023) · Italian Journal of Medicine · doi:10.4081/itjm.2023.1583 · Cited by 1
Nara, N., Kurosawa, Y., Fuse-Hamaoka, S., Kuroiwa, M., Endo, T., Tanaka, R., Kime, R., & Hamaoka, T. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17951 · Cited by 1
“This result is consistent with our previous findings that a single dose of 2,000 FU of NK did not affect the resting systolic and diastolic blood pressures of healthy normotensive men [8].”
ResultSelf-citationAcute and Subchronic Toxicities and Safety Pharmacology Studies of a Bacillus Subtilisin in Dogs
Xiao, S., Dong, Y., Hu, K., Hu, D., Zhou, L., & Wang, Y. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00659 · Cited by 3
Fujita, C., Usui, Y., & Inoue, M. (2022) · Food and Nutrition Sciences · doi:10.4236/fns.2022.133018 · Cited by 2
Therapeutic Enzymes Used for the Treatment of Cardiovascular Diseases and Coagulation Disorders
Khelfi, A. (2018) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-5225-5237-6.ch002
Kajian Enzim Fibrinolitik pada Mikroorganisme Asal Pangan Fermentasi Asia: Review
Syahbanu, F., & Pawestri, S. (2023) · Jurnal Teknologi Hasil Pertanian · doi:10.20961/jthp.v16i1.72623
Development of Novel Monoclonal Antibodies Against Nattokinase
Tanikawa, T., Yu, J., Hsu, K., Chen, S., Ishii, A., Yokogawa, T., Inoue, Y., & Kitamura, M. (2023) · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · doi:10.1089/mab.2023.0012
NATTOKINASE – USES AND BENEFITS
Hristova, M. (2023) · Trakia Journal of Sciences · doi:10.15547/tjs.2023.04.007
Metadata
- Authors
- Kurosawa, Y., Nirengi, S., Homma, T., Esaki, K., Ohta, M., Clark, J. F., & Hamaoka, T.
- Affiliations
- Ritsumeikan University (JP)
- Shunan University (JP)
- Kobe Pharmaceutical University (JP)
- University of Cincinnati (US)
- Corresponding author
- Hamaoka, Takafumi
- Venue
- Scientific Reports
- Published
- 2015-06-25
- Volume
- 5
- Issue
- 1
- Pages
- 11601-11601
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4479826
- OpenAlex
- W2404423380
- Cited by
- 115
- References
- 21
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 18 · 2023: 16 · 2022: 12 · 2021: 16 · 2020: 6 · 2019: 12 · 2018: 5 · 2017: 8 · 2016: 3
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- University of Cincinnati
- Japan Society for the Promotion of Science (26350824)
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Keywords
- nattokinase, fibrinolysis, coagulation, thrombolysis, anticoagulation, D-dimer, fibrin/fibrinogen degradation products, factor VIII, antithrombin III, activated partial thromboplastin time, single-dose administration, healthy men
- MeSH terms
- Antithrombins, Blood Coagulation, Blood Coagulation Tests, Double-Blind Method, Factor VIII, Fibrin, Fibrin Fibrinogen Degradation Products, Fibrinogen, Fibrinolysis, Fibrinolytic Agents, Humans, Male, Partial Thromboplastin Time, Subtilisins, Time Factors, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.